An Exploratory Study on the Development of a Novel Head Protection Prototype Device for Post-decompression Craniectomy Patients

Novel Head Protection Prototype Device for Decompression Craniectomy

Sponsors

Lead sponsor: Tan Tock Seng Hospital

Collaborator: Creatz3D

Source Tan Tock Seng Hospital
Brief Summary

A proof-of-concept (POC) proposal to study the feasibility of customized head protection prototype device (HPPD) using 3D printed externally-applied moulded skin prosthesis integrated to the craniectomy bony skull defect.

Detailed Description

A proof-of-concept (POC) proposal to study the feasibility of customized head protection prototype device (HPPD) using 3D printed externally-applied moulded skin prosthesis integrated to the craniectomy bony skull defect. The proposed material is a bio-compatible, light-weight rigid /semi rigid material which can be fitted to the skull defect and interfaced with the subject's bony rim using soft, deformable material (e.g. silicon) and attached using an elastic head band or other acceptable means. The prosthesis is removable for skin and prosthesis cleansing and ventilation.

Study Specific Objectives:

(i) Primary Objectives

These are to:

1. test the feasibility and safety of customised 3D printed HPPD,

2. integrate the prostheses to the skull defect in removable manner and discharge patient with appropriate education,

3. to systematically monitor subjects for symptoms, compliance, complications and subjective feedback during the outpatient phase where progressive wear of HPPD and monitoring of acceptability will be monitored.

Overall Status Recruiting
Start Date July 4, 2019
Completion Date March 31, 2020
Primary Completion Date March 31, 2020
Phase N/A
Study Type Interventional
Primary Outcome
Measure Time Frame
Percentage of acute complications at second hour of HPPD fitting 12 months
Secondary Outcome
Measure Time Frame
Percentage of acute complications at end of first week of HPPD use. 12 months
Enrollment 10
Condition
Intervention

Intervention type: Device

Intervention name: Head protection prototype device

Description: The proposed experimental HPPD uses biocompatible material using FDMÔNylon which has high fatigue resistance, chemical resistance with impact resistance and toughness which is free of powders. It is HSA unclassified as yet and the FDMONylon is not FDA approved yet.

Arm group label: Decompressive craniectomy

Eligibility

Criteria:

Inclusion Criteria:

All subjects must meet all of the inclusion criteria to participate in this study.

1. Age 21 to 80 years, both males and females.

2. Presence of surgical unilateral or bilateral craniectomy performed for reasons of ischaemic or haemorrhagic stroke, Subarachnoid haemorrhage (SAH), traumatic brain injury (TBI), benign cerebral tumours, etc.

3. Stroke, SAH or TBI are diagnosed by specialists and confirmed on brain imaging studies (CT, MRI)

4. Duration from event > 30 days and either during inpatient or outpatient phase.

5. Presence of at least 1 post decompressive craniectomy CT brain film performed at NNI/TTSH.

6. Healed craniectomy surgical wound without bulging skin flap or active skin infection.

7. Patients awaiting elective cranioplasty or those who refuse cranioplasty. 8 Ability to understand simple instructions and give own consent. 9 Presence of family members or NOK who can supervise the patient to don the head protection device, care for the material and regularly monitor for compliance and complications 10 Reproductive age females should not be pregnant at the point of consent-taking and during the study

Exclusion Criteria:

1. Patient in vegetative or minimally responsive state.

2. Presence of uncontrolled medical condition (uncontrolled hypertension, Diabetes Mellitus, sepsis or delirium, active malignancy either cranial or extracranial sites)

3. Presence of end organ failure (end stage renal or liver failure, renal dialysis, life expectancy <6 months)

4. Presence of pregnancy or lactation.

5. Presence of severe agitation /behavioural/active depression or anxiety/ drug or alcohol addiction which would negatively affect compliance,

6. Presence of unhealed head wound, active wound infection, scalp dermatitis, wound breakdown which would be worsened by pressure from the HPPD.

7. Presence of known allergy to the investigational products which is the 3D printed material (e.g. Nylon).

8. Subjects' CT brain imaging films are not available to the study team.

9. Absence of NOK who can assist monitoring unless subjects is able to self-monitor

Gender: All

Minimum age: 21 Years

Maximum age: 80 Years

Healthy volunteers: Accepts Healthy Volunteers

Overall Official
Last Name Role Affiliation
Khai Pang Leong Study Director Tan Tock Seng Hospital Clinical research and innovation office
Overall Contact

Last name: Karen SG Chua, MBBS, FRCPE

Phone: 65 68894580

Email: [email protected]

Location
facility status contact contact_backup investigator Tan Tock Seng Hospital Rehabilitation Centre Karen S Chua, MBBS, FRCP 6581263268 [email protected] Jia_Min Yen, MBBS, MRCP Sub-Investigator
Location Countries

Singapore

Verification Date

November 2019

Responsible Party

Responsible party type: Sponsor

Has Expanded Access No
Condition Browse
Number Of Arms 1
Arm Group

Arm group label: Decompressive craniectomy

Arm group type: Experimental

Description: 3D printed skull replacement piece will be fitted to subject.

Acronym HPPD
Patient Data No
Study Design Info

Allocation: N/A

Intervention model: Single Group Assignment

Intervention model description: Customised head protection prototype device.

Primary purpose: Other

Masking: None (Open Label)

Source: ClinicalTrials.gov